Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 11, 2003, Pages 1279-1285

  Benazon, Nili R ^a,b,c   Moore, Gregory J ^a   Rosenberg, David R ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Glutamate; Magnetic resonance spectroscopy; Obsessive compulsive disorder

Indexed keywords

BIOCHEMICAL MARKER; SEROTONIN UPTAKE INHIBITOR; DIAGNOSTIC AGENT; PROTON;

ADOLESCENT; ARTICLE; BEHAVIOR THERAPY; CAUDATE NUCLEUS; CHEMICAL ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; HAMILTON SCALE; HUMAN; NEUROCHEMISTRY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; SYMPTOM; TREATMENT OUTCOME; FEMALE; HEMISPHERIC DOMINANCE; MALE; METABOLISM; METHODOLOGY; PHYSIOLOGY; QUESTIONNAIRE;

ADOLESCENT; CAUDATE NUCLEUS; CHILD; COGNITIVE THERAPY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PROTONS; QUESTIONNAIRES;

EID: 0642365668     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000087562.01900.de     Document Type: Article

References (54)

1. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association
2. Ammons RB, Ammons CH (1962), Ammons Quick IQ Test. Psychological Test Specialists
3. Annett M (1967), The binomial distribution of right, mixed and left handedness. Q J Exp Psychol 19:327-333
4. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000), Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47:305-313
5. Baxter LR Jr, Schwartz JM, Bergman KS et al. (1992), Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49:681-689
6. Baxter LR Jr, Saxena S, Brody AL et al. (1996), Brain mediation of obsessive-compulsive disorder symptoms: evidence from functional brain imaging studies in the human and nonhuman primate. Semin Clin Neuropsychiatry 1:32-47
7. Becquet D, Faudon M, Hery F (1990), In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons. Brain Res 519:82-88
8. Benazon NR, Ager J, Rosenberg DR (2002), Cognitive behavior therapy in treatment-naïve children and adolescents with obsessive-compulsive disorder: an open trial. Behav Res Ther 40:529-539
9. 1H-NMR spectroscopic studies of brain. Neurosci Biobeh Rev 13:23-31
10. Bottomley PA (1987), Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333-348
11. Brody AL, Saxena S, Schwartz JM et al. (1998), FDG-PET predictors of response to behavioral therapy versus pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res 84:1-6
12. Calabresi P, Pisani A, Mercuri NB, Bernardi G (1996), The corticostriatal projection: from synaptic plasticity to dysfunction of the basal ganglia. Trends Neurosci 19:279-280
13. De Bellis MD, Keshavan MS, Spencer S, Hall J (2000), N-acetylaspartate concentration in the anterior cingulated of maltreated children and adolescents with PTSD. Am J Psychiatry 157:1175-1177
14. 3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization. Brain Res 733:21-30
15. Frahm J, Hanefeld F (1996), Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 26:64-69
16. Gilbert AR, Moore GJ, Keshavan MS et al. (2000), Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 57:449-456
17. Grados M, Scahill L, Riddle MA (1999), Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child Adolesc Psychiatr Clin North Am 8:617-634
18. Hamilton M (1959), The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
19. Hamilton M (1967), Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
20. Hollingshead A (1978), Four Factor Index of Social Status. New Haven, CT: Yale University, Department of Sociology
21. Kaufman J, Birmaher B, Prent D et al. (1997), Schedule of Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988
22. Kim JS, Hasller R, Hau P, Paik KS (1977), Effect of frontal cortex ablation on striatal glutamic acid level in rat. Brain Res 132:370-374
23. Knights RM, Norwood J (1980), Revised Smoothed Normative Data on the Neuropsychological test Battery for Children. Ottawa: Carlton University. Available at www.lafayetteinstitute.com
24. March JS, Mulle K, Herbei B (1994), Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder an open trial of a new protocol-driven treatment package. J Am Acad Child Adolesc Psychiatry 33:333-341
25. March JS, Mulle K (1998), OCD in Children and Adolescents: A Cognitive Behavioral Treatment Manual. New York: Guilford
26. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B (2003), Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology 28:720-725
27. Moore GJ, Bebchuk JM, Parrish JK et al. (1999), Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156:1902-1908
28. Moore GJ, Bebchuk JM, Hasanat K et al. (2000), Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neuroprotective effects? Biol Psychiatry 48:1-8
29. Onley JW (1991), Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry 26:505-525
30. Parent A, Hazrati NL (1995), Functional anatomy of the basal ganglia, I: The cortico-basal ganglia-thalanio-cortico loop. Brain Res Rev 20:91-127
31. Piacentini J, Bergman LR (2000), Obsessive-compulsive disorder in children. Psychiatr Clin North Am 23:519-533
32. Pfleiderer B, Michael N, Erfurth A et al. (2003), Effective electroconvulsive therapy reverses giutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res: Neuroimaging 122:185-192
33. Pitman RE, Green RC, Jenike MA, Mesulam MM (1987), Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry 144:1166-1171
34. Pouwels PJW, Frahm J (1998), Regional metabolite concentration in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39:53-60
35. 1H spectra with LC Model. NMR Biomed 14:260-264
36. Rasmussen SA, Eisen JL (1994), The epidemiology and differential diagnosis of obsessive-compulsive disorder. J Clin Psychiatry 55(Suppl 5):11-14
37. Rauch SL, Whalen PJ, Dougherty DD, Jenike MA (1998), Neurobiological models of obsessive-compulsive disorders. In: Obsessive Compulsive Disorders: Practical Management, Jenike MA, Baer L, Minichiello WE, eds. Boston: Mosby, pp 222-253
38. Rosenberg DR, Keshavan MS, O'Hearn KM et al. (1997), Fromo-scriatal measurement of treatment-naive pediatric obsessive-compulsive disorder. Arch Gen Psychiatry 54:824-830
39. Rosenberg DR, Keshavan MS (1998), Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 43:623-640
40. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ (2000), Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39:1096-1103
41. 1H spectroscopy: glutamate, glutamine, myoinositol and related metabolites. NMR Biomed 4:59-63
42. Saxena S, Brody AL, Schwartz JM, Baxter LR (1998), Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 173(Suppl 35):26-38
43. Saxena S, Brody AL, Maidment KM et al. (1999), Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 21:683-693
44. Scahill L, Riddle MA, McSwiggin-Hardin M et al. (1997), Children's Yale-Brown Obsessive-Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852
45. Schwartz JM (1996), Brain Lock. New York: Harper Collins
46. Schwartz JM, Stoessel PW, Baxter LR, Martin KM, Phelps ME (1996), Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53:109-113
47. 13C NMR measurement of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci USA 94:2699-2704
48. Smith Y, Parent A (1986), Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimtri sciureus). Neuroscience 18:347-371
49. Swedo SE, Rapoport JL, Cheslow DL et al. (1989), High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 146:246-249
50. Trites RL (1977), Neuropsychological Test Manual. Ottawa: Royal Ottawa Hospital
51. Valleni-Basile LA, Garrison CZ, Jackson KL et al. (1994), Frequency of obsessive-compulsive disorder in a community sample of young adolescent. J Am Acad Child Adolesc Psychiatry 33:782-791
52. Von Economo C (1931), Encephalitis Lethargica: Its Sequelae and Treatment. London: Oxford University Press
53. Wechsler D (1991), Wechsler Intelligence Scale for Children. New York: Psychological Corporation
54. Wolff RP, Wolff LS (1991), Assessment and treatment of obsessive-compulsive disorder in children. Behav Modif 15:372-393